| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.27 | 5e-10 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-09 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.19 | 4e-05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |